{"gene":"CLPP","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1998,"finding":"Human mitochondrial CLPP (hClpP) is synthesized as a precursor with an N-terminal mitochondrial targeting sequence (~56 residues) that is cleaved upon import into mitochondria in a membrane-potential-dependent manner; mature hClpP localizes to the mitochondrial matrix and co-localizes with Hsp60.","method":"Pulse-chase immunoprecipitation, cell-free mitochondrial import assay, confocal immunofluorescence co-localization with Hsp60","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (pulse-chase, import assay, immunofluorescence) in single study with rigorous controls","pmids":["9512494"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of human mitochondrial ClpP (hClpP) at 2.1 Å shows two heptameric rings enclosing a proteolytic chamber; N-terminal residues (8–16) form a mobile loop essential for ClpX-mediated protein and peptide degradation, and residues at the start of the unique 28-aa C-terminal domain affect heptamer assembly and stability.","method":"X-ray crystallography at 2.1 Å; site-directed mutagenesis and deletion of N-terminal loop/C-terminal domain with functional activity assays","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and functional validation","pmids":["15522782"],"is_preprint":false},{"year":2004,"finding":"ClpX–ClpP affinity is dynamically regulated during substrate processing: it varies with the protein-processing task of ClpX and with catalytic engagement of ClpP active sites; functional communication depends on ClpX ATPase activity transmitted through IGF loops, and a conserved arginine in the sensor II helix of ClpX links nucleotide state to ClpP binding.","method":"Biochemical binding and activity assays, mutagenesis of ClpX IGF loops and sensor II helix, ATP hydrolysis measurements","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and mechanistic dissection","pmids":["15064753"],"is_preprint":false},{"year":2005,"finding":"X-ray structure of S. pneumoniae ClpP(A153P) at 2.5 Å reveals that the handle region mediates ring–ring dimerization with unusual plasticity, and that flexible N-terminal loops lining the axial pores are essential determinants for ClpXP and ClpAP complex formation; truncation or mutation of loop residues impairs complex formation and uncouples ATPase–protease activity.","method":"X-ray crystallography at 2.5 Å; biochemical mutagenesis of N-terminal loop residues; ClpXP/ClpAP complex formation and activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structure plus mutagenesis with functional validation","pmids":["15701650"],"is_preprint":false},{"year":2004,"finding":"ClpA and ClpX hexamers bind simultaneously to opposite ends of the ClpP tetradecamer to form functional hybrid ClpXAP complexes that can independently translocate distinct substrate classes into ClpP without redistribution of the ATPase subunits.","method":"Electron microscopy visualization of substrate translocation into proteolytically inactive ClpP; in vitro reconstitution of hybrid complexes","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with direct EM visualization of substrate translocation","pmids":["15037252"],"is_preprint":false},{"year":2007,"finding":"In C. elegans, the mitochondrial matrix protease clpp-1 (ClpP homolog) is required for signaling the mitochondrial unfolded protein response (UPRmt): reduced clpp-1 activity attenuates nuclear redistribution of DVE-1, DVE-1/UBL-5 complex formation, and downstream chaperone gene induction.","method":"Genome-wide RNAi screen; RNAi knockdown of clpp-1 with reporter assays; ChIP showing DVE-1 binding to chaperone promoters","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — genome-wide screen validated with multiple mechanistic readouts; highly cited foundational paper","pmids":["17925224"],"is_preprint":false},{"year":2015,"finding":"Human mitochondrial CLPP interacts with respiratory chain proteins and metabolic enzymes; knockdown of CLPP in AML leukemic cells inhibits oxidative phosphorylation and mitochondrial metabolism, selectively killing leukemic cells with elevated CLPP expression.","method":"shRNA screen; Co-immunoprecipitation/MS identification of CLPP-interacting respiratory chain and metabolic proteins; genetic and chemical CLPP inhibition with OCR measurements","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP/MS plus KD with defined metabolic phenotype, replicated across cell lines and primary samples","pmids":["26058080"],"is_preprint":false},{"year":2019,"finding":"Imipridone compounds (ONC201 and analogues) bind human mitochondrial ClpP non-covalently in its hydrophobic pocket, activate proteolytic activity, cause selective degradation of respiratory chain protein substrates, and disrupt mitochondrial structure and function to kill cancer cells.","method":"Biochemical ClpP activity assays; X-ray crystallography of imipridone–ClpP complex; affinity chromatography/drug competition; siRNA knockdown rescue experiments","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structure, biochemical activation assays, and genetic rescue in single study","pmids":["31056398"],"is_preprint":false},{"year":2019,"finding":"ONC201 and TR analogue compounds directly bind human mitochondrial ClpP (identified by affinity chromatography/MS) and potently activate its peptidase activity in a dose- and time-dependent manner; siRNA knockdown of ClpP reduces cellular responses to these compounds including CHOP induction and loss of TFAM/TUFM.","method":"Affinity chromatography with immobilized TR compounds and MS identification; recombinant ClpP peptidase activity assay; siRNA knockdown with cellular phenotypic readouts","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1–2 — direct biochemical binding identification, in vitro enzyme assay, and genetic rescue","pmids":["31021596"],"is_preprint":false},{"year":2018,"finding":"ADEP analogues interact tightly with human mitochondrial ClpP (HsClpP), causing non-specific degradation of model substrates; ADEP–HsClpP co-crystal structure shows binding at hydrophobic pockets formed by two neighboring subunits, with HsClpP in the compact conformation; ADEP-mediated dysregulation activates intrinsic, caspase-dependent apoptosis.","method":"X-ray co-crystallography; in vitro peptidase activity assays; caspase activation assays; apoptosis assays","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with biochemical and cellular mechanistic validation","pmids":["30126533"],"is_preprint":false},{"year":2015,"finding":"Both AAA+ chaperones (ClpX) and ADEP small molecules activate ClpP through allosteric conformational control of the ClpP barrel; ADEP cooperatively binds the hydrophobic pocket, opens the axial pore, and directly stimulates active-site residues; substoichiometric ADEP potently prevents ClpX binding to ClpP.","method":"Chemical probes (activity-based profiling); NMR; biochemical binding and activity assays; ADEP-ClpP interaction studies","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods establishing allosteric mechanism","pmids":["25695750"],"is_preprint":false},{"year":2010,"finding":"ClpX binding stimulates ClpP cleavage of peptides larger than a few amino acids and enhances active-site modification; this stimulation requires ATP binding but not hydrolysis; channel loop and helix A residues of ClpP gate substrate entry, with ClpX binding relieving inhibitory interactions to allow translocation.","method":"In vitro peptide cleavage assays; active-site modification assays; ClpP channel variant mutagenesis with ClpXP translocation assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro system with systematic mutagenesis","pmids":["20416323"],"is_preprint":false},{"year":2008,"finding":"Removal of 10–17 N-terminal residues of mature E. coli ClpP allows ATPase-independent, processive degradation of unfolded proteins; the product size distribution of ΔN-ClpP is identical to ClpAP and ClpXP, indicating ATPases do not determine product size distribution.","method":"N-terminal deletion mutagenesis; in vitro protease activity assays on model unfolded substrate; product size analysis","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro mutagenesis study with mechanistic conclusions","pmids":["19038348"],"is_preprint":false},{"year":2008,"finding":"Crystal structures of Helicobacter pylori ClpP in apo form and in complex with product peptides show that peptides bind in antiparallel β-strand fashion at the active site, pointing to the adjacent active site; this explains broad substrate specificity, product inhibition, and processive degradation.","method":"X-ray crystallography of ClpP–peptide product complexes","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with substrate-bound complex providing mechanistic insight","pmids":["18468623"],"is_preprint":false},{"year":2011,"finding":"ADEP antibiotics activate bacterial ClpP to degrade the essential cell division protein FtsZ in vivo and in vitro, preventing Z-ring assembly and inhibiting septum formation; ADEP switches ClpP from a regulated to an uncontrolled protease.","method":"In vivo and in vitro degradation assays; fluorescence microscopy of cell division protein localization; genetic confirmation requiring ClpP","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution plus in vivo validation with multiple bacterial species","pmids":["21969594"],"is_preprint":false},{"year":2019,"finding":"Bortezomib binds the ClpP active-site serine (mimicking a peptide substrate) and induces allosteric activation of the entire tetradecameric ClpP complex; the activated conformation also exhibits higher affinity for cognate unfoldase ClpX, suggesting a universal allosteric mechanism for substrate-induced ClpP activation.","method":"X-ray crystallography; solid- and solution-state NMR; molecular dynamics simulations; isothermal titration calorimetry; biochemical activity assays","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — integrated structural and biophysical approach with multiple orthogonal methods","pmids":["31517045"],"is_preprint":false},{"year":2018,"finding":"A small molecule D9 acts as a potent, species-selective activator of human ClpP by mimicking the natural chaperone ClpX, interacting with a unique YYW aromatic amino acid network in hClpP that is absent in bacterial homologues; mutagenesis of this motif abolishes activation.","method":"Structure-activity relationship studies; mutational analysis of YYW motif; structural studies; species selectivity assays","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis plus structural validation with mechanistic dissection","pmids":["30129683"],"is_preprint":false},{"year":2018,"finding":"NMR, cryo-EM, and mutagenesis of S. aureus ClpP reveal that a hydrophobic site in the N-terminal domain acts as a conformational switch: mutation at this site unfolds N-terminal domains, abolishes activity, and creates a split-ring conformation with 20-Å pores in the complex side; ADEP binding to the hydrophobic pocket restores the extended active conformation.","method":"Methyl-TROSY NMR; cryo-EM; molecular dynamics simulations; biochemical activity assays; mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple structural methods plus mutagenesis and functional assays","pmids":["29941580"],"is_preprint":false},{"year":2013,"finding":"β-sultam compounds inhibit ClpP via two mechanisms: (1) substoichiometric binding induces disassembly of the active tetradecameric complex into inactive heptamers; (2) active-site serine undergoes covalent dehydroalanine formation through sulfonylation followed by elimination, obliterating the catalytic triad; confirmed by crystallography and mass spectrometry.","method":"X-ray crystallography; mass spectrometry; activity-based protein profiling in S. aureus cells; biochemical assembly assays","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus MS plus in-cell activity-based profiling","pmids":["24106749"],"is_preprint":false},{"year":2015,"finding":"Human mitochondrial ClpP, bacterial E. coli, and S. aureus ClpP exhibit defined preferences for certain amino acids at P1, P2, and P3 positions in fluorogenic substrate assays; however, during ClpXP-mediated degradation of endogenous substrates this specificity is attenuated, and the barrel architecture provides high local substrate concentrations enabling diverse cleavage.","method":"Fluorogenic substrate library profiling; MS analysis of ClpXP degradation products; customized substrates with unnatural amino acids; Perrault syndrome ClpP mutant activity profiling","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1 — multiple biochemical approaches with mechanistic conclusion","pmids":["26606371"],"is_preprint":false},{"year":2016,"finding":"Mammalian CLPP is neither required for, nor regulates the UPRmt in mammals: deletion of CLPP in DARS2-deficient hearts with robust UPRmt induction does not abolish UPRmt signaling, but instead alleviates severe mitochondrial cardiomyopathy and increases de novo synthesis of OXPHOS subunits.","method":"Genetic double knockout mouse model (DARS2/CLPP); OXPHOS subunit synthesis measurement; mitochondrial respiration assays; UPRmt marker analysis","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — epistasis in well-characterized double-KO mouse model with multiple mechanistic readouts","pmids":["27154400"],"is_preprint":false},{"year":2019,"finding":"α-Synuclein (αSyn) wild-type and A53T mutant physically interact with mitochondrial ClpP and suppress its peptidase activity; this binding shifts ClpP from soluble to insoluble cellular fraction, reduces ClpP levels in dopaminergic neurons, and causes mitochondrial oxidative damage; viral overexpression of ClpP rescues neuronal pathology.","method":"Co-immunoprecipitation; in vitro ClpP peptidase activity assay with αSyn; fractionation; viral ClpP overexpression in αSyn A53T mice with behavioral readouts","journal":"Acta neuropathologica","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, biochemical activity assay, and in vivo rescue experiment","pmids":["30877431"],"is_preprint":false},{"year":2021,"finding":"Loss of mitochondrial CLPP protease causes mtDNA instability and packaging alterations that lead to cytosolic mtDNA release, activating the cGAS-STING pathway and constitutive type I IFN signaling; pharmacological or genetic depletion of mtDNA or inhibition of cGAS-STING reduces antiviral gene expression in CLPP-null cells.","method":"CLPP-null mouse model; genetic and pharmacological cGAS-STING inhibition; mtDNA depletion; antiviral resistance assays; IFN reporter assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — epistasis with genetic and pharmacological approaches placing cGAS-STING downstream of CLPP","pmids":["33731338"],"is_preprint":false},{"year":2021,"finding":"Human mitochondrial CLPP and LONP1 cooperate to degrade shared substrates including SHMT2; both proteases share an extensive substrate pool encompassing OXPHOS, TCA cycle, fatty acid metabolism, and amino acid metabolism components, identified by APEX-mediated proximity biotinylation proteomics.","method":"Engineered peroxidase (APEX) proximity biotinylation proteomics; siRNA co-depletion of LONP1 and ClpP; cell viability and SHMT2 inhibitor sensitivity assays","journal":"Oncogenesis","confidence":"High","confidence_rationale":"Tier 2 — proximity proteomics with genetic validation and functional readouts","pmids":["33637676"],"is_preprint":false},{"year":2022,"finding":"Cryo-EM structures of ClpP-ATPase complexes reveal how a hexameric ATPase and tetradecameric ClpP work together; structures define the mechanism of substrate unfolding and translocation and reveal allosteric control of ClpP by small molecules and gain/loss-of-function mutations.","method":"Cryo-EM structural determination of ClpP-ATPase complexes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structural study with mechanistic conclusions","pmids":["35245501"],"is_preprint":false},{"year":2022,"finding":"Crystal structures of imipridone-derived ClpP activators in complex with human mitochondrial ClpP reveal enhanced binding due to greater shape/charge complementarity with surface hydrophobic pockets; N-terminome profiling of cancer cells identifies preferred structural motifs for cleavage by compound-activated ClpP.","method":"X-ray crystallography of compound-ClpP complexes; N-terminome profiling by MS; biochemical binding affinity assays","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 — crystal structures plus proteomic characterization of substrate cleavage motifs","pmids":["36586405"],"is_preprint":false},{"year":2020,"finding":"ADEP-activated ClpP alone (without any Clp-ATPase) unfolds and degrades the N-terminal domain of FtsZ in vitro; nucleotide binding to FtsZ stabilizes its fold and prevents this degradation; at elevated ADEP concentrations the FtsZ C-terminus is additionally targeted.","method":"In vitro ADEP-ClpP degradation assays with purified FtsZ; nucleotide stabilization rescue assay; N-terminal vs C-terminal domain degradation analysis","journal":"mBio","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mechanistic dissection of substrate domain accessibility","pmids":["32605984"],"is_preprint":false},{"year":2016,"finding":"A gain-of-function S. aureus ClpP mutant (Y63A) degrades FtsZ in vivo and inhibits bacterial growth; the crystal structure of Y63A ClpP and the cryo-EM structure of N42A/Y63A ClpP reveal an enlarged entrance pore as the structural basis for ATPase-independent proteolytic activation; ADEPs mimic the same activation mechanism.","method":"Crystal structure and cryo-EM of ClpP gain-of-function mutants; in vivo FtsZ degradation assay; whole-proteome MS of degraded proteins","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1 — structural determination plus in vivo functional validation","pmids":["27171654"],"is_preprint":false},{"year":2019,"finding":"IGF-motif loops of ClpX are required for ClpP docking; ATP/ATPγS binding changes ClpX ring conformation, bringing IGF loops closer together for multivalent ClpP contact; deletion of one or two IGF loops markedly accelerates ClpXP complex dissociation and reduces proteolytic processivity.","method":"Single-chain ClpX pseudohexamer IGF loop deletion mutagenesis; ClpXP association/dissociation kinetics; ATP-dependent degradation assays","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with quantitative kinetic and processivity measurements","pmids":["30767302"],"is_preprint":false},{"year":2015,"finding":"Knockdown of CLPP (~70%) in C2C12 muscle cells reduces mitochondrial respiration, alters mitochondrial morphology, changes expression of fission protein Drp1, blunts UPRmt induction, increases ROS, decreases membrane potential, impairs myoblast differentiation, reduces cell proliferation, and elevates eIF2α phosphorylation.","method":"siRNA and lentiviral shRNA stable knockdown; Seahorse respirometry; ROS measurement; membrane potential assay; differentiation and proliferation assays; immunoblotting","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with multiple phenotypic readouts, single lab","pmids":["26721594"],"is_preprint":false},{"year":2018,"finding":"ClpP knockout mice exhibit reduced adiposity, improved insulin sensitivity, increased whole-body energy expenditure, and selective upregulation of mitochondrial biogenesis markers in white adipose tissue; ClpP-/- mice are protected from diet-induced obesity and insulin resistance, indicating ClpP modulates mitochondrial biogenesis and metabolic signaling.","method":"ClpP knockout mouse model; metabolic phenotyping; high-fat diet challenge; energy expenditure measurement; WAT proteomic/gene expression analysis","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — rigorous in vivo KO model with metabolic phenotyping across multiple conditions","pmids":["29420235"],"is_preprint":false},{"year":2018,"finding":"CLPP mutations causing Perrault syndrome type 3 cluster in two functional regions: those near the hydrophobic pocket (T145P, C147S) that disrupt ClpX-docking with variable severity, and those adjacent to the active site (Y229D) that inhibit peptidase activity and unexpectedly also prevent ClpX docking, blocking both peptide and protein substrate turnover.","method":"Biochemical characterization of recombinant mutant CLPP proteins: oligomerization assays, ClpX-docking assays, peptidase activity assays, protein substrate turnover assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted biochemical analysis of disease mutations with multiple activity measurements","pmids":["30150665"],"is_preprint":false},{"year":2022,"finding":"ZK53, a selective human ClpP activator structurally distinct from ADEPs and imipridones, binds ClpP via π-π stacking as revealed by crystal structure; it causes ClpP-dependent decrease in electron transport chain components, reduces oxidative phosphorylation and ATP production, and activates ATM-mediated DNA damage response triggering cell cycle arrest in lung tumor cells.","method":"Crystal structure of ZK53/ClpP complex; ClpP-dependent rescue experiments; Seahorse OXPHOS assay; ATM pathway and cell cycle analysis; xenograft and autochthonous mouse models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus genetic rescue with in vivo validation","pmids":["37923710"],"is_preprint":false},{"year":2022,"finding":"ZG111, a ClpP activator identified by high-throughput screening, binds ClpP and promotes ClpP-mediated degradation of respiratory chain complexes, activating the JNK/c-Jun pathway and inducing ER stress response to cause PDAC cell growth arrest; efficacy confirmed in cell-line-derived and patient-derived xenograft mouse models.","method":"HTS; biochemical ClpP binding and activation assays; respiratory chain complex degradation; JNK/c-Jun pathway analysis; ER stress markers; PDX mouse models","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 2 — biochemical mechanism plus in vivo PDX validation","pmids":["35905743"],"is_preprint":false},{"year":2019,"finding":"Boron-containing α-aminoboronic acid peptidomimetics are the first inhibitors of human mitochondrial ClpXP, functioning as covalent inhibitors that prevent ClpP-mediated degradation of misfolded proteins.","method":"De novo virtual library design; biochemical ClpXP inhibition assays; cellular viability assays","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical assay with designed covalent inhibitors, single lab","pmids":["31187989"],"is_preprint":false},{"year":2008,"finding":"Frataxin deficiency in mouse heart causes progressive upregulation of both Lon and ClpP proteases with increased proteolytic activity; this correlates with progressive loss of mitochondrial Fe-S proteins, suggesting Fe-S proteins are substrates of these proteases during Friedreich ataxia progression.","method":"Western blotting for Lon and ClpP protein levels; proteolytic activity assays; measurement of Fe-S protein levels in frataxin-deficient mouse hearts at progressive disease stages","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 3 — correlative protease upregulation with functional activity assays, single lab","pmids":["19154341"],"is_preprint":false},{"year":2019,"finding":"ClpP overexpression reduces αSyn-induced mitochondrial oxidative stress by enhancing levels of SOD2, and suppresses αSyn S129 phosphorylation accumulation while promoting neuronal morphology in neurons derived from PD patient iPS cells.","method":"Viral ClpP overexpression in iPSC-derived neurons; SOD2 immunoblotting; αSyn S129 phosphorylation assay; neuronal morphology analysis","journal":"Acta neuropathologica","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function overexpression in relevant disease model with mechanistic readouts, single lab","pmids":["30877431"],"is_preprint":false}],"current_model":"Human mitochondrial CLPP is a serine protease that forms a tetradecameric (double heptameric ring) self-compartmentalized proteolytic chamber in the mitochondrial matrix; it functions as the proteolytic core of the ATP-dependent ClpXP complex, where ClpX hexamers bind via IGF loops to allosterically open CLPP's N-terminal gated axial pores, enabling unfolding, translocation, and degradation of substrates including respiratory chain components, TCA cycle enzymes, and misfolded/damaged proteins; small-molecule activators (imipridones, ADEPs, and analogues) hyperactivate CLPP by binding its hydrophobic surface pockets to mimic ClpX docking, causing uncontrolled proteolysis of OXPHOS substrates that selectively kills cancer cells, while disease-associated mutations (Perrault syndrome) disrupt either the hydrophobic ClpX-docking pocket or the catalytic active site; loss of CLPP triggers mtDNA instability leading to cGAS-STING-dependent type I IFN signaling, and CLPP is also suppressed by α-synuclein binding which inhibits its peptidase activity and promotes its insolubility."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that hClpP is a mitochondrial matrix protease with a cleavable targeting sequence resolved its subcellular localization and set the stage for understanding its role in mitochondrial protein quality control.","evidence":"Pulse-chase immunoprecipitation, cell-free mitochondrial import assay, and confocal immunofluorescence co-localization with Hsp60 in human cells","pmids":["9512494"],"confidence":"High","gaps":["Endogenous substrates in the matrix were unknown","Whether hClpP required a cognate ATPase partner was not yet established"]},{"year":2004,"claim":"Structural and biochemical studies revealed the tetradecameric barrel architecture, identified N-terminal gating loops and the ClpX IGF-loop docking mechanism, and showed that ClpX–ClpP affinity is dynamically regulated during substrate processing, establishing the core operating principles of the ClpXP machine.","evidence":"X-ray crystallography of hClpP at 2.1 Å with mutagenesis; biochemical binding/activity assays with ClpX IGF-loop and sensor-II mutations; EM visualization of hybrid ClpXAP complexes","pmids":["15522782","15064753","15037252"],"confidence":"High","gaps":["Structural basis of the ClpX–ClpP interface at atomic resolution was not yet available","Substrate identity for human ClpXP was unknown"]},{"year":2008,"claim":"Deletion of N-terminal gating residues converted ClpP into an ATPase-independent protease capable of processive degradation, demonstrating that the axial pore is the principal barrier to substrate entry and that the barrel itself determines product size.","evidence":"N-terminal deletion mutagenesis of E. coli ClpP with in vitro protease assays and product size analysis","pmids":["19038348","18468623"],"confidence":"High","gaps":["Whether human ClpP N-terminal gating behaved identically was not tested","Regulation of pore opening in vivo remained unclear"]},{"year":2007,"claim":"An RNAi screen in C. elegans identified clpp-1 as essential for mitochondrial unfolded protein response (UPRmt) signaling, linking ClpP protease activity to a retrograde stress signaling pathway.","evidence":"Genome-wide RNAi screen; DVE-1 relocalization and chaperone reporter assays in C. elegans","pmids":["17925224"],"confidence":"High","gaps":["Whether this role was conserved in mammals was untested","The signal peptide generated by ClpP for UPRmt was not identified"]},{"year":2010,"claim":"Biochemical dissection showed that ClpX binding relieves inhibitory interactions at the ClpP channel, stimulating cleavage of larger peptides even without ATP hydrolysis, establishing that allosteric pore gating—not just substrate delivery—is a key function of the ATPase.","evidence":"In vitro peptide cleavage and active-site modification assays with ClpP channel variant mutagenesis","pmids":["20416323"],"confidence":"High","gaps":["Structural visualization of the open vs closed pore states was lacking","How gating relates to substrate selectivity in vivo was unknown"]},{"year":2015,"claim":"Two convergent discoveries revealed that ADEP small molecules and ClpX activate ClpP through the same allosteric mechanism at the hydrophobic pocket, and that CLPP interacts with respiratory chain and metabolic enzymes whose degradation upon CLPP knockdown selectively kills leukemic cells.","evidence":"Activity-based profiling, NMR, and biochemical assays for ADEP/ClpX allostery; Co-IP/MS identification of CLPP-interacting proteins plus shRNA screen in AML cells","pmids":["25695750","26058080"],"confidence":"High","gaps":["Structural basis for ADEP–human ClpP interaction was not yet resolved","Whether CLPP activation could be exploited therapeutically in solid tumors was untested"]},{"year":2016,"claim":"Mammalian CLPP was shown to be dispensable for UPRmt signaling, overturning the C. elegans paradigm; separately, CLPP knockout mice displayed increased energy expenditure and resistance to diet-induced obesity, revealing metabolic regulatory functions.","evidence":"Double knockout DARS2/CLPP mouse model with UPRmt marker analysis; ClpP-null mouse metabolic phenotyping and high-fat diet challenge","pmids":["27154400","29420235"],"confidence":"High","gaps":["Tissue-specific roles of CLPP in metabolic regulation were not fully delineated","Molecular substrates driving the lean phenotype were unidentified"]},{"year":2018,"claim":"Biochemical characterization of Perrault syndrome mutations mapped disease mechanisms to two functional classes—hydrophobic pocket mutations disrupting ClpX docking and active-site-adjacent mutations abolishing both catalysis and docking—establishing genotype–mechanism correlations for this Mendelian disorder.","evidence":"Recombinant mutant CLPP oligomerization, ClpX-docking, peptidase, and protein substrate turnover assays","pmids":["30150665"],"confidence":"High","gaps":["How partial loss of ClpXP activity leads specifically to ovarian and auditory phenotypes was unexplained","Patient-derived cell models were not employed"]},{"year":2019,"claim":"Identification of imipridones (ONC201 and analogues) as direct ClpP-binding activators provided a chemically tractable scaffold for cancer therapy; structural and genetic evidence confirmed that ClpP is the functional target mediating OXPHOS collapse and cancer cell death.","evidence":"X-ray crystallography of imipridone–ClpP complex; affinity chromatography/MS target identification; siRNA knockdown rescue; cellular OXPHOS and viability assays","pmids":["31056398","31021596"],"confidence":"High","gaps":["Clinical efficacy in patients was not yet demonstrated","Whether resistance mechanisms could bypass ClpP activation was unknown"]},{"year":2019,"claim":"α-Synuclein was identified as a direct ClpP interactor that suppresses its peptidase activity and promotes its insolubility, linking ClpP dysfunction to Parkinson's disease pathology; ClpP overexpression rescued neuronal damage.","evidence":"Co-immunoprecipitation; in vitro ClpP peptidase assay with α-synuclein; viral ClpP overexpression rescue in α-synuclein A53T mice and iPSC-derived neurons","pmids":["30877431"],"confidence":"High","gaps":["Whether α-synuclein inhibits ClpP by direct active-site occlusion or allosteric mechanism was unresolved","Whether ClpP overexpression is neuroprotective in other PD models was untested"]},{"year":2021,"claim":"CLPP loss was shown to cause mtDNA instability and cytosolic release, activating cGAS-STING-dependent type I IFN signaling, establishing an innate immune consequence of mitochondrial protease deficiency; CLPP and LONP1 were found to share an extensive substrate pool.","evidence":"CLPP-null mouse model with genetic/pharmacological cGAS-STING inhibition and mtDNA depletion; APEX proximity proteomics for CLPP/LONP1 substrate overlap","pmids":["33731338","33637676"],"confidence":"High","gaps":["Whether cGAS-STING activation contributes to Perrault syndrome pathology was untested","The mechanism by which CLPP loss destabilizes mtDNA packaging was unknown"]},{"year":2022,"claim":"Cryo-EM structures of ClpP–ATPase complexes and crystal structures of next-generation activators (ZK53, ZG111, imipridone derivatives) defined the structural basis for allosteric activation and substrate cleavage preferences, and demonstrated in vivo anti-tumor efficacy across multiple cancer models.","evidence":"Cryo-EM of ClpP–ATPase complexes; crystal structures of ZK53/ClpP and activator/ClpP complexes; N-terminome profiling; xenograft and PDX mouse models","pmids":["35245501","37923710","35905743","36586405"],"confidence":"High","gaps":["Full-length human ClpXP holoenyzme structure at high resolution is still lacking","In vivo substrate hierarchy during pharmacological activation is not defined"]},{"year":null,"claim":"Key open questions include the identity of the peptide signals generated by ClpP that communicate mitochondrial stress to the nucleus, the tissue-specific substrate repertoire explaining Perrault syndrome's organ selectivity, and the structural basis for selectivity among chemically diverse ClpP activator scaffolds in clinical settings.","evidence":"","pmids":[],"confidence":"Low","gaps":["Retrograde signaling peptides produced by ClpP remain unidentified","Tissue-specific ClpXP substrate profiles have not been mapped","Resistance mechanisms to ClpP activators in tumors are unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,7,9,11,19,23,25]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[1,9,12,13,19]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,1,6,7,22,23]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[6,7,9,23,25]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[6,23,30]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[22]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[9,32]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,22,29]}],"complexes":["ClpXP"],"partners":["CLPX","LONP1","SNCA","SHMT2"],"other_free_text":[]},"mechanistic_narrative":"CLPP is a mitochondrial matrix serine protease that assembles as a tetradecameric barrel (two stacked heptameric rings) and serves as the proteolytic core of the ATP-dependent ClpXP complex, where ClpX hexamers dock via IGF-loop motifs to allosterically open N-terminal axial pores and translocate substrates for processive degradation [PMID:15522782, PMID:15064753, PMID:20416323, PMID:35245501]. CLPP cooperates with LONP1 to degrade a broad substrate repertoire encompassing OXPHOS subunits, TCA cycle enzymes, and other mitochondrial metabolic proteins, and its loss causes mtDNA instability leading to cytosolic mtDNA release and cGAS-STING-dependent type I interferon signaling [PMID:33637676, PMID:33731338, PMID:26058080]. Small-molecule activators—imipridones, ADEPs, and structurally distinct compounds—bind hydrophobic pockets at subunit interfaces to mimic ClpX docking and trigger uncontrolled proteolysis of respiratory chain components, selectively killing cancer cells through OXPHOS collapse and apoptosis [PMID:31056398, PMID:30126533, PMID:37923710]. Biallelic CLPP mutations cause Perrault syndrome type 3 by disrupting either the hydrophobic ClpX-docking pocket or the catalytic active site [PMID:30150665]."},"prefetch_data":{"uniprot":{"accession":"Q16740","full_name":"ATP-dependent Clp protease proteolytic subunit, mitochondrial","aliases":["Caseinolytic mitochondrial matrix peptidase proteolytic subunit","Endopeptidase Clp"],"length_aa":277,"mass_kda":30.2,"function":"Protease component of the ClpXP complex that cleaves peptides and various proteins in an ATP-dependent process. Has low peptidase activity in the absence of CLPX. The ClpXP complex can degrade CSN1S1, CSN2 and CSN3, as well as synthetic peptides (in vitro) and may be responsible for a fairly general and central housekeeping function rather than for the degradation of specific substrates (PubMed:11923310, PubMed:15522782). Cleaves PINK1 in the mitochondrion (PubMed:22354088)","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/Q16740/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLPP","classification":"Not Classified","n_dependent_lines":63,"n_total_lines":1208,"dependency_fraction":0.052152317880794705},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CLPP","total_profiled":1310},"omim":[{"mim_id":"619518","title":"MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO","url":"https://www.omim.org/entry/619518"},{"mim_id":"618015","title":"PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2","url":"https://www.omim.org/entry/618015"},{"mim_id":"615611","title":"CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE CHAPERONE SUBUNIT; CLPX","url":"https://www.omim.org/entry/615611"},{"mim_id":"614324","title":"OVARIAN DYSGENESIS 3; ODG3","url":"https://www.omim.org/entry/614324"},{"mim_id":"614129","title":"PERRAULT SYNDROME 3; PRLTS3","url":"https://www.omim.org/entry/614129"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CLPP"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q16740","domains":[{"cath_id":"3.90.226.10","chopping":"71-249","consensus_level":"high","plddt":97.3059,"start":71,"end":249}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16740","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16740-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16740-F1-predicted_aligned_error_v6.png","plddt_mean":82.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLPP","jax_strain_url":"https://www.jax.org/strain/search?query=CLPP"},"sequence":{"accession":"Q16740","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16740.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16740/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16740"}},"corpus_meta":[{"pmid":"17925224","id":"PMC_17925224","title":"ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans.","date":"2007","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/17925224","citation_count":495,"is_preprint":false},{"pmid":"31056398","id":"PMC_31056398","title":"Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.","date":"2019","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/31056398","citation_count":294,"is_preprint":false},{"pmid":"26058080","id":"PMC_26058080","title":"Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia.","date":"2015","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/26058080","citation_count":292,"is_preprint":false},{"pmid":"12791139","id":"PMC_12791139","title":"Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence.","date":"2003","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12791139","citation_count":264,"is_preprint":false},{"pmid":"17302811","id":"PMC_17302811","title":"Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria.","date":"2007","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17302811","citation_count":234,"is_preprint":false},{"pmid":"18657233","id":"PMC_18657233","title":"CLB19, a pentatricopeptide repeat protein required for editing of rpoA and clpP chloroplast transcripts.","date":"2008","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18657233","citation_count":212,"is_preprint":false},{"pmid":"10760131","id":"PMC_10760131","title":"The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes.","date":"2000","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10760131","citation_count":212,"is_preprint":false},{"pmid":"9535081","id":"PMC_9535081","title":"ClpP of Bacillus subtilis is required for competence development, motility, degradative enzyme synthesis, growth at high temperature and sporulation.","date":"1998","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9535081","citation_count":190,"is_preprint":false},{"pmid":"16885446","id":"PMC_16885446","title":"Global regulatory impact of ClpP protease of Staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair.","date":"2006","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/16885446","citation_count":179,"is_preprint":false},{"pmid":"31021596","id":"PMC_31021596","title":"Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.","date":"2019","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31021596","citation_count":156,"is_preprint":false},{"pmid":"21969594","id":"PMC_21969594","title":"Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21969594","citation_count":147,"is_preprint":false},{"pmid":"18638561","id":"PMC_18638561","title":"Complete plastid genome sequence of the chickpea (Cicer arietinum) and the phylogenetic distribution of rps12 and clpP intron losses among legumes (Leguminosae).","date":"2008","source":"Molecular phylogenetics and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/18638561","citation_count":141,"is_preprint":false},{"pmid":"15064753","id":"PMC_15064753","title":"Communication between ClpX and ClpP during substrate processing and degradation.","date":"2004","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15064753","citation_count":124,"is_preprint":false},{"pmid":"12057945","id":"PMC_12057945","title":"Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence.","date":"2002","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/12057945","citation_count":121,"is_preprint":false},{"pmid":"29775273","id":"PMC_29775273","title":"The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases.","date":"2018","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/29775273","citation_count":117,"is_preprint":false},{"pmid":"9987112","id":"PMC_9987112","title":"ClpP participates in the degradation of misfolded protein in Lactococcus lactis.","date":"1999","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9987112","citation_count":113,"is_preprint":false},{"pmid":"21628539","id":"PMC_21628539","title":"walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.","date":"2011","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/21628539","citation_count":113,"is_preprint":false},{"pmid":"33037181","id":"PMC_33037181","title":"Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33037181","citation_count":111,"is_preprint":false},{"pmid":"12399506","id":"PMC_12399506","title":"Regulation and Physiological Significance of ClpC and ClpP in Streptococcus mutans.","date":"2002","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/12399506","citation_count":109,"is_preprint":false},{"pmid":"25695750","id":"PMC_25695750","title":"AAA+ chaperones and acyldepsipeptides activate the ClpP protease via conformational control.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25695750","citation_count":107,"is_preprint":false},{"pmid":"15701650","id":"PMC_15701650","title":"The ClpP double ring tetradecameric protease exhibits plastic ring-ring interactions, and the N termini of its subunits form flexible loops that are essential for ClpXP and ClpAP complex formation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15701650","citation_count":102,"is_preprint":false},{"pmid":"27154400","id":"PMC_27154400","title":"Loss of CLPP alleviates mitochondrial cardiomyopathy without affecting the mammalian UPRmt.","date":"2016","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/27154400","citation_count":101,"is_preprint":false},{"pmid":"10540290","id":"PMC_10540290","title":"Effects of DksA and ClpP protease on sigma S production and virulence in Salmonella typhimurium.","date":"1999","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10540290","citation_count":100,"is_preprint":false},{"pmid":"15522782","id":"PMC_15522782","title":"Crystallography and mutagenesis point to an essential role for the N-terminus of human mitochondrial ClpP.","date":"2004","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/15522782","citation_count":99,"is_preprint":false},{"pmid":"24879428","id":"PMC_24879428","title":"Conditional Depletion of the Chlamydomonas Chloroplast ClpP Protease Activates Nuclear Genes Involved in Autophagy and Plastid Protein Quality Control.","date":"2014","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/24879428","citation_count":98,"is_preprint":false},{"pmid":"2211522","id":"PMC_2211522","title":"The ClpP component of Clp protease is the sigma 32-dependent heat shock protein F21.5.","date":"1990","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2211522","citation_count":98,"is_preprint":false},{"pmid":"23253041","id":"PMC_23253041","title":"Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus.","date":"2013","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/23253041","citation_count":97,"is_preprint":false},{"pmid":"30126533","id":"PMC_30126533","title":"Acyldepsipeptide Analogs Dysregulate Human Mitochondrial ClpP Protease Activity and Cause Apoptotic Cell Death.","date":"2018","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30126533","citation_count":94,"is_preprint":false},{"pmid":"12486047","id":"PMC_12486047","title":"Global role for ClpP-containing proteases in stationary-phase adaptation of Escherichia coli.","date":"2003","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/12486047","citation_count":89,"is_preprint":false},{"pmid":"26721594","id":"PMC_26721594","title":"Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation.","date":"2015","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26721594","citation_count":80,"is_preprint":false},{"pmid":"29420235","id":"PMC_29420235","title":"Loss of mitochondrial protease ClpP protects mice from diet-induced obesity and insulin resistance.","date":"2018","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29420235","citation_count":76,"is_preprint":false},{"pmid":"30877431","id":"PMC_30877431","title":"Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.","date":"2019","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/30877431","citation_count":71,"is_preprint":false},{"pmid":"17890122","id":"PMC_17890122","title":"Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis.","date":"2007","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/17890122","citation_count":71,"is_preprint":false},{"pmid":"19154341","id":"PMC_19154341","title":"Frataxin deficiency causes upregulation of mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe-S proteins.","date":"2008","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/19154341","citation_count":69,"is_preprint":false},{"pmid":"18378094","id":"PMC_18378094","title":"Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13).","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18378094","citation_count":67,"is_preprint":false},{"pmid":"17283080","id":"PMC_17283080","title":"A Pentatricopeptide repeat protein is required for RNA processing of clpP Pre-mRNA in moss chloroplasts.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17283080","citation_count":66,"is_preprint":false},{"pmid":"20416323","id":"PMC_20416323","title":"Control of substrate gating and translocation into ClpP by channel residues and ClpX binding.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20416323","citation_count":66,"is_preprint":false},{"pmid":"10455123","id":"PMC_10455123","title":"Signal peptide peptidase- and ClpP-like proteins of Bacillus subtilis required for efficient translocation and processing of secretory proteins.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10455123","citation_count":63,"is_preprint":false},{"pmid":"22112206","id":"PMC_22112206","title":"New insights into Staphylococcus aureus stress tolerance and virulence regulation from an analysis of the role of the ClpP protease in the strains Newman, COL, and SA564.","date":"2011","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/22112206","citation_count":57,"is_preprint":false},{"pmid":"15317791","id":"PMC_15317791","title":"The ClpP peptidase is the major determinant of bulk protein turnover in Bacillus subtilis.","date":"2004","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/15317791","citation_count":57,"is_preprint":false},{"pmid":"9512494","id":"PMC_9512494","title":"A human homologue of Escherichia coli ClpP caseinolytic protease: recombinant expression, intracellular processing and subcellular localization.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9512494","citation_count":55,"is_preprint":false},{"pmid":"33637676","id":"PMC_33637676","title":"LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival.","date":"2021","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33637676","citation_count":54,"is_preprint":false},{"pmid":"35245501","id":"PMC_35245501","title":"Recent structural insights into the mechanism of ClpP protease regulation by AAA+ chaperones and small molecules.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35245501","citation_count":54,"is_preprint":false},{"pmid":"30129683","id":"PMC_30129683","title":"Selective Activation of Human Caseinolytic Protease P (ClpP).","date":"2018","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/30129683","citation_count":53,"is_preprint":false},{"pmid":"20038588","id":"PMC_20038588","title":"ClpP of Streptococcus mutans differentially regulates expression of genomic islands, mutacin production, and antibiotic tolerance.","date":"2009","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/20038588","citation_count":52,"is_preprint":false},{"pmid":"10555973","id":"PMC_10555973","title":"ClpA and ClpP remain associated during multiple rounds of ATP-dependent protein degradation by ClpAP protease.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10555973","citation_count":51,"is_preprint":false},{"pmid":"35905743","id":"PMC_35905743","title":"Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma.","date":"2022","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/35905743","citation_count":49,"is_preprint":false},{"pmid":"29941580","id":"PMC_29941580","title":"Reversible inhibition of the ClpP protease via an N-terminal conformational switch.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29941580","citation_count":49,"is_preprint":false},{"pmid":"10972808","id":"PMC_10972808","title":"Mutations conferring amino acid residue substitutions in the carboxy-terminal domain of RNA polymerase alpha can suppress clpX and clpP with respect to developmentally regulated transcription in Bacillus subtilis.","date":"2000","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10972808","citation_count":49,"is_preprint":false},{"pmid":"23326465","id":"PMC_23326465","title":"The ClpP protease is required for the stress tolerance and biofilm formation in Actinobacillus pleuropneumoniae.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23326465","citation_count":48,"is_preprint":false},{"pmid":"15037252","id":"PMC_15037252","title":"ClpA and ClpX ATPases bind simultaneously to opposite ends of ClpP peptidase to form active hybrid complexes.","date":"2004","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/15037252","citation_count":48,"is_preprint":false},{"pmid":"34446368","id":"PMC_34446368","title":"Substrates and interactors of the ClpP protease in the mitochondria.","date":"2021","source":"Current opinion in chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/34446368","citation_count":47,"is_preprint":false},{"pmid":"31241890","id":"PMC_31241890","title":"Chemical Modulation of Human Mitochondrial ClpP: Potential Application in Cancer Therapeutics.","date":"2019","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31241890","citation_count":47,"is_preprint":false},{"pmid":"27831584","id":"PMC_27831584","title":"The development of small-molecule modulators for ClpP protease activity.","date":"2016","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/27831584","citation_count":45,"is_preprint":false},{"pmid":"33731338","id":"PMC_33731338","title":"Loss of Mitochondrial Protease CLPP Activates Type I IFN Responses through the Mitochondrial DNA-cGAS-STING Signaling Axis.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/33731338","citation_count":45,"is_preprint":false},{"pmid":"31517045","id":"PMC_31517045","title":"Mechanism of the allosteric activation of the ClpP protease machinery by substrates and active-site inhibitors.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31517045","citation_count":45,"is_preprint":false},{"pmid":"28555174","id":"PMC_28555174","title":"The ATP-Dependent Protease ClpP Inhibits Biofilm Formation by Regulating Agr and Cell Wall Hydrolase Sle1 in Staphylococcus aureus.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28555174","citation_count":44,"is_preprint":false},{"pmid":"24106749","id":"PMC_24106749","title":"Disruption of oligomerization and dehydroalanine formation as mechanisms for ClpP protease inhibition.","date":"2013","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24106749","citation_count":44,"is_preprint":false},{"pmid":"9593294","id":"PMC_9593294","title":"ClpX and ClpP are essential for the efficient acquisition of genes specifying type IA and IB restriction systems.","date":"1998","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9593294","citation_count":43,"is_preprint":false},{"pmid":"18468623","id":"PMC_18468623","title":"The structural basis for the activation and peptide recognition of bacterial ClpP.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18468623","citation_count":43,"is_preprint":false},{"pmid":"30878663","id":"PMC_30878663","title":"Senescent Hepatocytes in Decompensated Liver Show Reduced UPRMT and Its Key Player, CLPP, Attenuates Senescence In Vitro.","date":"2019","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/30878663","citation_count":41,"is_preprint":false},{"pmid":"36586405","id":"PMC_36586405","title":"Potent ClpP agonists with anticancer properties bind with improved structural complementarity and alter the mitochondrial N-terminome.","date":"2022","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/36586405","citation_count":39,"is_preprint":false},{"pmid":"16946256","id":"PMC_16946256","title":"Construction and characterization of a Lactococcus lactis strain deficient in intracellular ClpP and extracellular HtrA proteases.","date":"2006","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16946256","citation_count":39,"is_preprint":false},{"pmid":"37923710","id":"PMC_37923710","title":"Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37923710","citation_count":38,"is_preprint":false},{"pmid":"18689476","id":"PMC_18689476","title":"Polar localization and compartmentalization of ClpP proteases during growth and sporulation in Bacillus subtilis.","date":"2008","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/18689476","citation_count":38,"is_preprint":false},{"pmid":"35319277","id":"PMC_35319277","title":"Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia.","date":"2022","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/35319277","citation_count":37,"is_preprint":false},{"pmid":"19038348","id":"PMC_19038348","title":"Turned on for degradation: ATPase-independent degradation by ClpP.","date":"2008","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/19038348","citation_count":37,"is_preprint":false},{"pmid":"25956234","id":"PMC_25956234","title":"Exome analysis identified a novel missense mutation in the CLPP gene in a consanguineous Saudi family expanding the clinical spectrum of Perrault Syndrome type-3.","date":"2015","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25956234","citation_count":37,"is_preprint":false},{"pmid":"35929764","id":"PMC_35929764","title":"Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP.","date":"2022","source":"Pharmacology research & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/35929764","citation_count":36,"is_preprint":false},{"pmid":"16321946","id":"PMC_16321946","title":"The ClgR protein regulates transcription of the clpP operon in Bifidobacterium breve UCC 2003.","date":"2005","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/16321946","citation_count":36,"is_preprint":false},{"pmid":"31187989","id":"PMC_31187989","title":"De Novo Design of Boron-Based Peptidomimetics as Potent Inhibitors of Human ClpP in the Presence of Human ClpX.","date":"2019","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31187989","citation_count":36,"is_preprint":false},{"pmid":"26606371","id":"PMC_26606371","title":"Barrel-shaped ClpP Proteases Display Attenuated Cleavage Specificities.","date":"2015","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/26606371","citation_count":35,"is_preprint":false},{"pmid":"23560081","id":"PMC_23560081","title":"Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23560081","citation_count":35,"is_preprint":false},{"pmid":"30150665","id":"PMC_30150665","title":"Perrault syndrome type 3 caused by diverse molecular defects in CLPP.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30150665","citation_count":35,"is_preprint":false},{"pmid":"35246663","id":"PMC_35246663","title":"ClpP inhibitors are produced by a widespread family of bacterial gene clusters.","date":"2022","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/35246663","citation_count":34,"is_preprint":false},{"pmid":"32033530","id":"PMC_32033530","title":"ClpP participates in stress tolerance, biofilm formation, antimicrobial tolerance, and virulence of Enterococcus faecalis.","date":"2020","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32033530","citation_count":34,"is_preprint":false},{"pmid":"9115246","id":"PMC_9115246","title":"Identification of an unusual intein in chloroplast ClpP protease of Chlamydomonas eugametos.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9115246","citation_count":34,"is_preprint":false},{"pmid":"36533084","id":"PMC_36533084","title":"Cellular functions of the ClpP protease impacting bacterial virulence.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36533084","citation_count":33,"is_preprint":false},{"pmid":"35421426","id":"PMC_35421426","title":"Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice.","date":"2022","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35421426","citation_count":32,"is_preprint":false},{"pmid":"12177472","id":"PMC_12177472","title":"Overexpression of the clpP 5'-untranslated region in a chimeric context causes a mutant phenotype, suggesting competition for a clpP-specific RNA maturation factor in tobacco chloroplasts.","date":"2002","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12177472","citation_count":31,"is_preprint":false},{"pmid":"18992803","id":"PMC_18992803","title":"Helicobacter pylori mutants defective in the clpP ATP-dependant protease and the chaperone clpA display reduced macrophage and murine survival.","date":"2008","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18992803","citation_count":31,"is_preprint":false},{"pmid":"27171654","id":"PMC_27171654","title":"Characterization of Gain-of-Function Mutant Provides New Insights into ClpP Structure.","date":"2016","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/27171654","citation_count":31,"is_preprint":false},{"pmid":"32605984","id":"PMC_32605984","title":"Cell Division Protein FtsZ Is Unfolded for N-Terminal Degradation by Antibiotic-Activated ClpP.","date":"2020","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/32605984","citation_count":29,"is_preprint":false},{"pmid":"27375177","id":"PMC_27375177","title":"Effect of clpP and clpC deletion on persister cell number in Staphylococcus aureus.","date":"2016","source":"Journal of medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27375177","citation_count":29,"is_preprint":false},{"pmid":"31399403","id":"PMC_31399403","title":"The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory clpP Gene as a Novel Antibiotic Resistance Factor.","date":"2019","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31399403","citation_count":29,"is_preprint":false},{"pmid":"30767302","id":"PMC_30767302","title":"Roles of the ClpX IGF loops in ClpP association, dissociation, and protein degradation.","date":"2019","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/30767302","citation_count":28,"is_preprint":false},{"pmid":"15967532","id":"PMC_15967532","title":"Lon and ClpP proteases participate in the physiological disintegration of bacterial inclusion bodies.","date":"2005","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15967532","citation_count":28,"is_preprint":false},{"pmid":"25212124","id":"PMC_25212124","title":"A simple fragment of cyclic acyldepsipeptides is necessary and sufficient for ClpP activation and antibacterial activity.","date":"2014","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/25212124","citation_count":28,"is_preprint":false},{"pmid":"31178057","id":"PMC_31178057","title":"Role of ClpX and ClpP in Streptococcus suis serotype 2 stress tolerance and virulence.","date":"2019","source":"Microbiological research","url":"https://pubmed.ncbi.nlm.nih.gov/31178057","citation_count":27,"is_preprint":false},{"pmid":"35417530","id":"PMC_35417530","title":"Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.","date":"2022","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/35417530","citation_count":27,"is_preprint":false},{"pmid":"33210542","id":"PMC_33210542","title":"Global Inventory of ClpP- and ClpX-Regulated Proteins in Staphylococcus aureus.","date":"2020","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/33210542","citation_count":26,"is_preprint":false},{"pmid":"33237740","id":"PMC_33237740","title":"Development of Antibiotics That Dysregulate the Neisserial ClpP Protease.","date":"2020","source":"ACS infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33237740","citation_count":26,"is_preprint":false},{"pmid":"12624203","id":"PMC_12624203","title":"Role of the Streptococcus agalactiae ClpP serine protease in heat-induced stress defence and growth arrest.","date":"2003","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12624203","citation_count":26,"is_preprint":false},{"pmid":"32031798","id":"PMC_32031798","title":"Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers in Vitro and in Vivo.","date":"2020","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32031798","citation_count":25,"is_preprint":false},{"pmid":"30396899","id":"PMC_30396899","title":"Initial Characterization of the Two ClpP Paralogs of Chlamydia trachomatis Suggests Unique Functionality for Each.","date":"2018","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/30396899","citation_count":25,"is_preprint":false},{"pmid":"36388465","id":"PMC_36388465","title":"Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.","date":"2022","source":"Cancer research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36388465","citation_count":25,"is_preprint":false},{"pmid":"23676436","id":"PMC_23676436","title":"ClpP deletion causes attenuation of Salmonella Typhimurium virulence through mis-regulation of RpoS and indirect control of CsrA and the SPI genes.","date":"2013","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23676436","citation_count":25,"is_preprint":false},{"pmid":"27899912","id":"PMC_27899912","title":"Specific MRI Abnormalities Reveal Severe Perrault Syndrome due to CLPP Defects.","date":"2016","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27899912","citation_count":25,"is_preprint":false},{"pmid":"27484084","id":"PMC_27484084","title":"ClpP-deletion impairs the virulence of Legionella pneumophila and the optimal translocation of effector proteins.","date":"2016","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27484084","citation_count":24,"is_preprint":false},{"pmid":"37589388","id":"PMC_37589388","title":"A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.","date":"2024","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37589388","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46884,"output_tokens":8221,"usd":0.131984},"stage2":{"model":"claude-opus-4-6","input_tokens":12117,"output_tokens":3302,"usd":0.214702},"total_usd":0.346686,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Human mitochondrial CLPP (hClpP) is synthesized as a precursor with an N-terminal mitochondrial targeting sequence (~56 residues) that is cleaved upon import into mitochondria in a membrane-potential-dependent manner; mature hClpP localizes to the mitochondrial matrix and co-localizes with Hsp60.\",\n      \"method\": \"Pulse-chase immunoprecipitation, cell-free mitochondrial import assay, confocal immunofluorescence co-localization with Hsp60\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (pulse-chase, import assay, immunofluorescence) in single study with rigorous controls\",\n      \"pmids\": [\"9512494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of human mitochondrial ClpP (hClpP) at 2.1 Å shows two heptameric rings enclosing a proteolytic chamber; N-terminal residues (8–16) form a mobile loop essential for ClpX-mediated protein and peptide degradation, and residues at the start of the unique 28-aa C-terminal domain affect heptamer assembly and stability.\",\n      \"method\": \"X-ray crystallography at 2.1 Å; site-directed mutagenesis and deletion of N-terminal loop/C-terminal domain with functional activity assays\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and functional validation\",\n      \"pmids\": [\"15522782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ClpX–ClpP affinity is dynamically regulated during substrate processing: it varies with the protein-processing task of ClpX and with catalytic engagement of ClpP active sites; functional communication depends on ClpX ATPase activity transmitted through IGF loops, and a conserved arginine in the sensor II helix of ClpX links nucleotide state to ClpP binding.\",\n      \"method\": \"Biochemical binding and activity assays, mutagenesis of ClpX IGF loops and sensor II helix, ATP hydrolysis measurements\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and mechanistic dissection\",\n      \"pmids\": [\"15064753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"X-ray structure of S. pneumoniae ClpP(A153P) at 2.5 Å reveals that the handle region mediates ring–ring dimerization with unusual plasticity, and that flexible N-terminal loops lining the axial pores are essential determinants for ClpXP and ClpAP complex formation; truncation or mutation of loop residues impairs complex formation and uncouples ATPase–protease activity.\",\n      \"method\": \"X-ray crystallography at 2.5 Å; biochemical mutagenesis of N-terminal loop residues; ClpXP/ClpAP complex formation and activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure plus mutagenesis with functional validation\",\n      \"pmids\": [\"15701650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ClpA and ClpX hexamers bind simultaneously to opposite ends of the ClpP tetradecamer to form functional hybrid ClpXAP complexes that can independently translocate distinct substrate classes into ClpP without redistribution of the ATPase subunits.\",\n      \"method\": \"Electron microscopy visualization of substrate translocation into proteolytically inactive ClpP; in vitro reconstitution of hybrid complexes\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with direct EM visualization of substrate translocation\",\n      \"pmids\": [\"15037252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In C. elegans, the mitochondrial matrix protease clpp-1 (ClpP homolog) is required for signaling the mitochondrial unfolded protein response (UPRmt): reduced clpp-1 activity attenuates nuclear redistribution of DVE-1, DVE-1/UBL-5 complex formation, and downstream chaperone gene induction.\",\n      \"method\": \"Genome-wide RNAi screen; RNAi knockdown of clpp-1 with reporter assays; ChIP showing DVE-1 binding to chaperone promoters\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide screen validated with multiple mechanistic readouts; highly cited foundational paper\",\n      \"pmids\": [\"17925224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Human mitochondrial CLPP interacts with respiratory chain proteins and metabolic enzymes; knockdown of CLPP in AML leukemic cells inhibits oxidative phosphorylation and mitochondrial metabolism, selectively killing leukemic cells with elevated CLPP expression.\",\n      \"method\": \"shRNA screen; Co-immunoprecipitation/MS identification of CLPP-interacting respiratory chain and metabolic proteins; genetic and chemical CLPP inhibition with OCR measurements\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP/MS plus KD with defined metabolic phenotype, replicated across cell lines and primary samples\",\n      \"pmids\": [\"26058080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Imipridone compounds (ONC201 and analogues) bind human mitochondrial ClpP non-covalently in its hydrophobic pocket, activate proteolytic activity, cause selective degradation of respiratory chain protein substrates, and disrupt mitochondrial structure and function to kill cancer cells.\",\n      \"method\": \"Biochemical ClpP activity assays; X-ray crystallography of imipridone–ClpP complex; affinity chromatography/drug competition; siRNA knockdown rescue experiments\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure, biochemical activation assays, and genetic rescue in single study\",\n      \"pmids\": [\"31056398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ONC201 and TR analogue compounds directly bind human mitochondrial ClpP (identified by affinity chromatography/MS) and potently activate its peptidase activity in a dose- and time-dependent manner; siRNA knockdown of ClpP reduces cellular responses to these compounds including CHOP induction and loss of TFAM/TUFM.\",\n      \"method\": \"Affinity chromatography with immobilized TR compounds and MS identification; recombinant ClpP peptidase activity assay; siRNA knockdown with cellular phenotypic readouts\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct biochemical binding identification, in vitro enzyme assay, and genetic rescue\",\n      \"pmids\": [\"31021596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ADEP analogues interact tightly with human mitochondrial ClpP (HsClpP), causing non-specific degradation of model substrates; ADEP–HsClpP co-crystal structure shows binding at hydrophobic pockets formed by two neighboring subunits, with HsClpP in the compact conformation; ADEP-mediated dysregulation activates intrinsic, caspase-dependent apoptosis.\",\n      \"method\": \"X-ray co-crystallography; in vitro peptidase activity assays; caspase activation assays; apoptosis assays\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with biochemical and cellular mechanistic validation\",\n      \"pmids\": [\"30126533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Both AAA+ chaperones (ClpX) and ADEP small molecules activate ClpP through allosteric conformational control of the ClpP barrel; ADEP cooperatively binds the hydrophobic pocket, opens the axial pore, and directly stimulates active-site residues; substoichiometric ADEP potently prevents ClpX binding to ClpP.\",\n      \"method\": \"Chemical probes (activity-based profiling); NMR; biochemical binding and activity assays; ADEP-ClpP interaction studies\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods establishing allosteric mechanism\",\n      \"pmids\": [\"25695750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ClpX binding stimulates ClpP cleavage of peptides larger than a few amino acids and enhances active-site modification; this stimulation requires ATP binding but not hydrolysis; channel loop and helix A residues of ClpP gate substrate entry, with ClpX binding relieving inhibitory interactions to allow translocation.\",\n      \"method\": \"In vitro peptide cleavage assays; active-site modification assays; ClpP channel variant mutagenesis with ClpXP translocation assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro system with systematic mutagenesis\",\n      \"pmids\": [\"20416323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Removal of 10–17 N-terminal residues of mature E. coli ClpP allows ATPase-independent, processive degradation of unfolded proteins; the product size distribution of ΔN-ClpP is identical to ClpAP and ClpXP, indicating ATPases do not determine product size distribution.\",\n      \"method\": \"N-terminal deletion mutagenesis; in vitro protease activity assays on model unfolded substrate; product size analysis\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro mutagenesis study with mechanistic conclusions\",\n      \"pmids\": [\"19038348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structures of Helicobacter pylori ClpP in apo form and in complex with product peptides show that peptides bind in antiparallel β-strand fashion at the active site, pointing to the adjacent active site; this explains broad substrate specificity, product inhibition, and processive degradation.\",\n      \"method\": \"X-ray crystallography of ClpP–peptide product complexes\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with substrate-bound complex providing mechanistic insight\",\n      \"pmids\": [\"18468623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ADEP antibiotics activate bacterial ClpP to degrade the essential cell division protein FtsZ in vivo and in vitro, preventing Z-ring assembly and inhibiting septum formation; ADEP switches ClpP from a regulated to an uncontrolled protease.\",\n      \"method\": \"In vivo and in vitro degradation assays; fluorescence microscopy of cell division protein localization; genetic confirmation requiring ClpP\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus in vivo validation with multiple bacterial species\",\n      \"pmids\": [\"21969594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bortezomib binds the ClpP active-site serine (mimicking a peptide substrate) and induces allosteric activation of the entire tetradecameric ClpP complex; the activated conformation also exhibits higher affinity for cognate unfoldase ClpX, suggesting a universal allosteric mechanism for substrate-induced ClpP activation.\",\n      \"method\": \"X-ray crystallography; solid- and solution-state NMR; molecular dynamics simulations; isothermal titration calorimetry; biochemical activity assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — integrated structural and biophysical approach with multiple orthogonal methods\",\n      \"pmids\": [\"31517045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A small molecule D9 acts as a potent, species-selective activator of human ClpP by mimicking the natural chaperone ClpX, interacting with a unique YYW aromatic amino acid network in hClpP that is absent in bacterial homologues; mutagenesis of this motif abolishes activation.\",\n      \"method\": \"Structure-activity relationship studies; mutational analysis of YYW motif; structural studies; species selectivity assays\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus structural validation with mechanistic dissection\",\n      \"pmids\": [\"30129683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NMR, cryo-EM, and mutagenesis of S. aureus ClpP reveal that a hydrophobic site in the N-terminal domain acts as a conformational switch: mutation at this site unfolds N-terminal domains, abolishes activity, and creates a split-ring conformation with 20-Å pores in the complex side; ADEP binding to the hydrophobic pocket restores the extended active conformation.\",\n      \"method\": \"Methyl-TROSY NMR; cryo-EM; molecular dynamics simulations; biochemical activity assays; mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple structural methods plus mutagenesis and functional assays\",\n      \"pmids\": [\"29941580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"β-sultam compounds inhibit ClpP via two mechanisms: (1) substoichiometric binding induces disassembly of the active tetradecameric complex into inactive heptamers; (2) active-site serine undergoes covalent dehydroalanine formation through sulfonylation followed by elimination, obliterating the catalytic triad; confirmed by crystallography and mass spectrometry.\",\n      \"method\": \"X-ray crystallography; mass spectrometry; activity-based protein profiling in S. aureus cells; biochemical assembly assays\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus MS plus in-cell activity-based profiling\",\n      \"pmids\": [\"24106749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Human mitochondrial ClpP, bacterial E. coli, and S. aureus ClpP exhibit defined preferences for certain amino acids at P1, P2, and P3 positions in fluorogenic substrate assays; however, during ClpXP-mediated degradation of endogenous substrates this specificity is attenuated, and the barrel architecture provides high local substrate concentrations enabling diverse cleavage.\",\n      \"method\": \"Fluorogenic substrate library profiling; MS analysis of ClpXP degradation products; customized substrates with unnatural amino acids; Perrault syndrome ClpP mutant activity profiling\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biochemical approaches with mechanistic conclusion\",\n      \"pmids\": [\"26606371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mammalian CLPP is neither required for, nor regulates the UPRmt in mammals: deletion of CLPP in DARS2-deficient hearts with robust UPRmt induction does not abolish UPRmt signaling, but instead alleviates severe mitochondrial cardiomyopathy and increases de novo synthesis of OXPHOS subunits.\",\n      \"method\": \"Genetic double knockout mouse model (DARS2/CLPP); OXPHOS subunit synthesis measurement; mitochondrial respiration assays; UPRmt marker analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis in well-characterized double-KO mouse model with multiple mechanistic readouts\",\n      \"pmids\": [\"27154400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"α-Synuclein (αSyn) wild-type and A53T mutant physically interact with mitochondrial ClpP and suppress its peptidase activity; this binding shifts ClpP from soluble to insoluble cellular fraction, reduces ClpP levels in dopaminergic neurons, and causes mitochondrial oxidative damage; viral overexpression of ClpP rescues neuronal pathology.\",\n      \"method\": \"Co-immunoprecipitation; in vitro ClpP peptidase activity assay with αSyn; fractionation; viral ClpP overexpression in αSyn A53T mice with behavioral readouts\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, biochemical activity assay, and in vivo rescue experiment\",\n      \"pmids\": [\"30877431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of mitochondrial CLPP protease causes mtDNA instability and packaging alterations that lead to cytosolic mtDNA release, activating the cGAS-STING pathway and constitutive type I IFN signaling; pharmacological or genetic depletion of mtDNA or inhibition of cGAS-STING reduces antiviral gene expression in CLPP-null cells.\",\n      \"method\": \"CLPP-null mouse model; genetic and pharmacological cGAS-STING inhibition; mtDNA depletion; antiviral resistance assays; IFN reporter assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with genetic and pharmacological approaches placing cGAS-STING downstream of CLPP\",\n      \"pmids\": [\"33731338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human mitochondrial CLPP and LONP1 cooperate to degrade shared substrates including SHMT2; both proteases share an extensive substrate pool encompassing OXPHOS, TCA cycle, fatty acid metabolism, and amino acid metabolism components, identified by APEX-mediated proximity biotinylation proteomics.\",\n      \"method\": \"Engineered peroxidase (APEX) proximity biotinylation proteomics; siRNA co-depletion of LONP1 and ClpP; cell viability and SHMT2 inhibitor sensitivity assays\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proximity proteomics with genetic validation and functional readouts\",\n      \"pmids\": [\"33637676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structures of ClpP-ATPase complexes reveal how a hexameric ATPase and tetradecameric ClpP work together; structures define the mechanism of substrate unfolding and translocation and reveal allosteric control of ClpP by small molecules and gain/loss-of-function mutations.\",\n      \"method\": \"Cryo-EM structural determination of ClpP-ATPase complexes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structural study with mechanistic conclusions\",\n      \"pmids\": [\"35245501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Crystal structures of imipridone-derived ClpP activators in complex with human mitochondrial ClpP reveal enhanced binding due to greater shape/charge complementarity with surface hydrophobic pockets; N-terminome profiling of cancer cells identifies preferred structural motifs for cleavage by compound-activated ClpP.\",\n      \"method\": \"X-ray crystallography of compound-ClpP complexes; N-terminome profiling by MS; biochemical binding affinity assays\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures plus proteomic characterization of substrate cleavage motifs\",\n      \"pmids\": [\"36586405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ADEP-activated ClpP alone (without any Clp-ATPase) unfolds and degrades the N-terminal domain of FtsZ in vitro; nucleotide binding to FtsZ stabilizes its fold and prevents this degradation; at elevated ADEP concentrations the FtsZ C-terminus is additionally targeted.\",\n      \"method\": \"In vitro ADEP-ClpP degradation assays with purified FtsZ; nucleotide stabilization rescue assay; N-terminal vs C-terminal domain degradation analysis\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mechanistic dissection of substrate domain accessibility\",\n      \"pmids\": [\"32605984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A gain-of-function S. aureus ClpP mutant (Y63A) degrades FtsZ in vivo and inhibits bacterial growth; the crystal structure of Y63A ClpP and the cryo-EM structure of N42A/Y63A ClpP reveal an enlarged entrance pore as the structural basis for ATPase-independent proteolytic activation; ADEPs mimic the same activation mechanism.\",\n      \"method\": \"Crystal structure and cryo-EM of ClpP gain-of-function mutants; in vivo FtsZ degradation assay; whole-proteome MS of degraded proteins\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural determination plus in vivo functional validation\",\n      \"pmids\": [\"27171654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IGF-motif loops of ClpX are required for ClpP docking; ATP/ATPγS binding changes ClpX ring conformation, bringing IGF loops closer together for multivalent ClpP contact; deletion of one or two IGF loops markedly accelerates ClpXP complex dissociation and reduces proteolytic processivity.\",\n      \"method\": \"Single-chain ClpX pseudohexamer IGF loop deletion mutagenesis; ClpXP association/dissociation kinetics; ATP-dependent degradation assays\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with quantitative kinetic and processivity measurements\",\n      \"pmids\": [\"30767302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Knockdown of CLPP (~70%) in C2C12 muscle cells reduces mitochondrial respiration, alters mitochondrial morphology, changes expression of fission protein Drp1, blunts UPRmt induction, increases ROS, decreases membrane potential, impairs myoblast differentiation, reduces cell proliferation, and elevates eIF2α phosphorylation.\",\n      \"method\": \"siRNA and lentiviral shRNA stable knockdown; Seahorse respirometry; ROS measurement; membrane potential assay; differentiation and proliferation assays; immunoblotting\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with multiple phenotypic readouts, single lab\",\n      \"pmids\": [\"26721594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ClpP knockout mice exhibit reduced adiposity, improved insulin sensitivity, increased whole-body energy expenditure, and selective upregulation of mitochondrial biogenesis markers in white adipose tissue; ClpP-/- mice are protected from diet-induced obesity and insulin resistance, indicating ClpP modulates mitochondrial biogenesis and metabolic signaling.\",\n      \"method\": \"ClpP knockout mouse model; metabolic phenotyping; high-fat diet challenge; energy expenditure measurement; WAT proteomic/gene expression analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous in vivo KO model with metabolic phenotyping across multiple conditions\",\n      \"pmids\": [\"29420235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLPP mutations causing Perrault syndrome type 3 cluster in two functional regions: those near the hydrophobic pocket (T145P, C147S) that disrupt ClpX-docking with variable severity, and those adjacent to the active site (Y229D) that inhibit peptidase activity and unexpectedly also prevent ClpX docking, blocking both peptide and protein substrate turnover.\",\n      \"method\": \"Biochemical characterization of recombinant mutant CLPP proteins: oligomerization assays, ClpX-docking assays, peptidase activity assays, protein substrate turnover assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted biochemical analysis of disease mutations with multiple activity measurements\",\n      \"pmids\": [\"30150665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ZK53, a selective human ClpP activator structurally distinct from ADEPs and imipridones, binds ClpP via π-π stacking as revealed by crystal structure; it causes ClpP-dependent decrease in electron transport chain components, reduces oxidative phosphorylation and ATP production, and activates ATM-mediated DNA damage response triggering cell cycle arrest in lung tumor cells.\",\n      \"method\": \"Crystal structure of ZK53/ClpP complex; ClpP-dependent rescue experiments; Seahorse OXPHOS assay; ATM pathway and cell cycle analysis; xenograft and autochthonous mouse models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus genetic rescue with in vivo validation\",\n      \"pmids\": [\"37923710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ZG111, a ClpP activator identified by high-throughput screening, binds ClpP and promotes ClpP-mediated degradation of respiratory chain complexes, activating the JNK/c-Jun pathway and inducing ER stress response to cause PDAC cell growth arrest; efficacy confirmed in cell-line-derived and patient-derived xenograft mouse models.\",\n      \"method\": \"HTS; biochemical ClpP binding and activation assays; respiratory chain complex degradation; JNK/c-Jun pathway analysis; ER stress markers; PDX mouse models\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biochemical mechanism plus in vivo PDX validation\",\n      \"pmids\": [\"35905743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Boron-containing α-aminoboronic acid peptidomimetics are the first inhibitors of human mitochondrial ClpXP, functioning as covalent inhibitors that prevent ClpP-mediated degradation of misfolded proteins.\",\n      \"method\": \"De novo virtual library design; biochemical ClpXP inhibition assays; cellular viability assays\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical assay with designed covalent inhibitors, single lab\",\n      \"pmids\": [\"31187989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Frataxin deficiency in mouse heart causes progressive upregulation of both Lon and ClpP proteases with increased proteolytic activity; this correlates with progressive loss of mitochondrial Fe-S proteins, suggesting Fe-S proteins are substrates of these proteases during Friedreich ataxia progression.\",\n      \"method\": \"Western blotting for Lon and ClpP protein levels; proteolytic activity assays; measurement of Fe-S protein levels in frataxin-deficient mouse hearts at progressive disease stages\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — correlative protease upregulation with functional activity assays, single lab\",\n      \"pmids\": [\"19154341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ClpP overexpression reduces αSyn-induced mitochondrial oxidative stress by enhancing levels of SOD2, and suppresses αSyn S129 phosphorylation accumulation while promoting neuronal morphology in neurons derived from PD patient iPS cells.\",\n      \"method\": \"Viral ClpP overexpression in iPSC-derived neurons; SOD2 immunoblotting; αSyn S129 phosphorylation assay; neuronal morphology analysis\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function overexpression in relevant disease model with mechanistic readouts, single lab\",\n      \"pmids\": [\"30877431\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human mitochondrial CLPP is a serine protease that forms a tetradecameric (double heptameric ring) self-compartmentalized proteolytic chamber in the mitochondrial matrix; it functions as the proteolytic core of the ATP-dependent ClpXP complex, where ClpX hexamers bind via IGF loops to allosterically open CLPP's N-terminal gated axial pores, enabling unfolding, translocation, and degradation of substrates including respiratory chain components, TCA cycle enzymes, and misfolded/damaged proteins; small-molecule activators (imipridones, ADEPs, and analogues) hyperactivate CLPP by binding its hydrophobic surface pockets to mimic ClpX docking, causing uncontrolled proteolysis of OXPHOS substrates that selectively kills cancer cells, while disease-associated mutations (Perrault syndrome) disrupt either the hydrophobic ClpX-docking pocket or the catalytic active site; loss of CLPP triggers mtDNA instability leading to cGAS-STING-dependent type I IFN signaling, and CLPP is also suppressed by α-synuclein binding which inhibits its peptidase activity and promotes its insolubility.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CLPP is a mitochondrial matrix serine protease that assembles as a tetradecameric barrel (two stacked heptameric rings) and serves as the proteolytic core of the ATP-dependent ClpXP complex, where ClpX hexamers dock via IGF-loop motifs to allosterically open N-terminal axial pores and translocate substrates for processive degradation [PMID:15522782, PMID:15064753, PMID:20416323, PMID:35245501]. CLPP cooperates with LONP1 to degrade a broad substrate repertoire encompassing OXPHOS subunits, TCA cycle enzymes, and other mitochondrial metabolic proteins, and its loss causes mtDNA instability leading to cytosolic mtDNA release and cGAS-STING-dependent type I interferon signaling [PMID:33637676, PMID:33731338, PMID:26058080]. Small-molecule activators—imipridones, ADEPs, and structurally distinct compounds—bind hydrophobic pockets at subunit interfaces to mimic ClpX docking and trigger uncontrolled proteolysis of respiratory chain components, selectively killing cancer cells through OXPHOS collapse and apoptosis [PMID:31056398, PMID:30126533, PMID:37923710]. Biallelic CLPP mutations cause Perrault syndrome type 3 by disrupting either the hydrophobic ClpX-docking pocket or the catalytic active site [PMID:30150665].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that hClpP is a mitochondrial matrix protease with a cleavable targeting sequence resolved its subcellular localization and set the stage for understanding its role in mitochondrial protein quality control.\",\n      \"evidence\": \"Pulse-chase immunoprecipitation, cell-free mitochondrial import assay, and confocal immunofluorescence co-localization with Hsp60 in human cells\",\n      \"pmids\": [\"9512494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrates in the matrix were unknown\", \"Whether hClpP required a cognate ATPase partner was not yet established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Structural and biochemical studies revealed the tetradecameric barrel architecture, identified N-terminal gating loops and the ClpX IGF-loop docking mechanism, and showed that ClpX–ClpP affinity is dynamically regulated during substrate processing, establishing the core operating principles of the ClpXP machine.\",\n      \"evidence\": \"X-ray crystallography of hClpP at 2.1 Å with mutagenesis; biochemical binding/activity assays with ClpX IGF-loop and sensor-II mutations; EM visualization of hybrid ClpXAP complexes\",\n      \"pmids\": [\"15522782\", \"15064753\", \"15037252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the ClpX–ClpP interface at atomic resolution was not yet available\", \"Substrate identity for human ClpXP was unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Deletion of N-terminal gating residues converted ClpP into an ATPase-independent protease capable of processive degradation, demonstrating that the axial pore is the principal barrier to substrate entry and that the barrel itself determines product size.\",\n      \"evidence\": \"N-terminal deletion mutagenesis of E. coli ClpP with in vitro protease assays and product size analysis\",\n      \"pmids\": [\"19038348\", \"18468623\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether human ClpP N-terminal gating behaved identically was not tested\", \"Regulation of pore opening in vivo remained unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"An RNAi screen in C. elegans identified clpp-1 as essential for mitochondrial unfolded protein response (UPRmt) signaling, linking ClpP protease activity to a retrograde stress signaling pathway.\",\n      \"evidence\": \"Genome-wide RNAi screen; DVE-1 relocalization and chaperone reporter assays in C. elegans\",\n      \"pmids\": [\"17925224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this role was conserved in mammals was untested\", \"The signal peptide generated by ClpP for UPRmt was not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Biochemical dissection showed that ClpX binding relieves inhibitory interactions at the ClpP channel, stimulating cleavage of larger peptides even without ATP hydrolysis, establishing that allosteric pore gating—not just substrate delivery—is a key function of the ATPase.\",\n      \"evidence\": \"In vitro peptide cleavage and active-site modification assays with ClpP channel variant mutagenesis\",\n      \"pmids\": [\"20416323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural visualization of the open vs closed pore states was lacking\", \"How gating relates to substrate selectivity in vivo was unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Two convergent discoveries revealed that ADEP small molecules and ClpX activate ClpP through the same allosteric mechanism at the hydrophobic pocket, and that CLPP interacts with respiratory chain and metabolic enzymes whose degradation upon CLPP knockdown selectively kills leukemic cells.\",\n      \"evidence\": \"Activity-based profiling, NMR, and biochemical assays for ADEP/ClpX allostery; Co-IP/MS identification of CLPP-interacting proteins plus shRNA screen in AML cells\",\n      \"pmids\": [\"25695750\", \"26058080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for ADEP–human ClpP interaction was not yet resolved\", \"Whether CLPP activation could be exploited therapeutically in solid tumors was untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mammalian CLPP was shown to be dispensable for UPRmt signaling, overturning the C. elegans paradigm; separately, CLPP knockout mice displayed increased energy expenditure and resistance to diet-induced obesity, revealing metabolic regulatory functions.\",\n      \"evidence\": \"Double knockout DARS2/CLPP mouse model with UPRmt marker analysis; ClpP-null mouse metabolic phenotyping and high-fat diet challenge\",\n      \"pmids\": [\"27154400\", \"29420235\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific roles of CLPP in metabolic regulation were not fully delineated\", \"Molecular substrates driving the lean phenotype were unidentified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Biochemical characterization of Perrault syndrome mutations mapped disease mechanisms to two functional classes—hydrophobic pocket mutations disrupting ClpX docking and active-site-adjacent mutations abolishing both catalysis and docking—establishing genotype–mechanism correlations for this Mendelian disorder.\",\n      \"evidence\": \"Recombinant mutant CLPP oligomerization, ClpX-docking, peptidase, and protein substrate turnover assays\",\n      \"pmids\": [\"30150665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How partial loss of ClpXP activity leads specifically to ovarian and auditory phenotypes was unexplained\", \"Patient-derived cell models were not employed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of imipridones (ONC201 and analogues) as direct ClpP-binding activators provided a chemically tractable scaffold for cancer therapy; structural and genetic evidence confirmed that ClpP is the functional target mediating OXPHOS collapse and cancer cell death.\",\n      \"evidence\": \"X-ray crystallography of imipridone–ClpP complex; affinity chromatography/MS target identification; siRNA knockdown rescue; cellular OXPHOS and viability assays\",\n      \"pmids\": [\"31056398\", \"31021596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Clinical efficacy in patients was not yet demonstrated\", \"Whether resistance mechanisms could bypass ClpP activation was unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"α-Synuclein was identified as a direct ClpP interactor that suppresses its peptidase activity and promotes its insolubility, linking ClpP dysfunction to Parkinson's disease pathology; ClpP overexpression rescued neuronal damage.\",\n      \"evidence\": \"Co-immunoprecipitation; in vitro ClpP peptidase assay with α-synuclein; viral ClpP overexpression rescue in α-synuclein A53T mice and iPSC-derived neurons\",\n      \"pmids\": [\"30877431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether α-synuclein inhibits ClpP by direct active-site occlusion or allosteric mechanism was unresolved\", \"Whether ClpP overexpression is neuroprotective in other PD models was untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CLPP loss was shown to cause mtDNA instability and cytosolic release, activating cGAS-STING-dependent type I IFN signaling, establishing an innate immune consequence of mitochondrial protease deficiency; CLPP and LONP1 were found to share an extensive substrate pool.\",\n      \"evidence\": \"CLPP-null mouse model with genetic/pharmacological cGAS-STING inhibition and mtDNA depletion; APEX proximity proteomics for CLPP/LONP1 substrate overlap\",\n      \"pmids\": [\"33731338\", \"33637676\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cGAS-STING activation contributes to Perrault syndrome pathology was untested\", \"The mechanism by which CLPP loss destabilizes mtDNA packaging was unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cryo-EM structures of ClpP–ATPase complexes and crystal structures of next-generation activators (ZK53, ZG111, imipridone derivatives) defined the structural basis for allosteric activation and substrate cleavage preferences, and demonstrated in vivo anti-tumor efficacy across multiple cancer models.\",\n      \"evidence\": \"Cryo-EM of ClpP–ATPase complexes; crystal structures of ZK53/ClpP and activator/ClpP complexes; N-terminome profiling; xenograft and PDX mouse models\",\n      \"pmids\": [\"35245501\", \"37923710\", \"35905743\", \"36586405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length human ClpXP holoenyzme structure at high resolution is still lacking\", \"In vivo substrate hierarchy during pharmacological activation is not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the identity of the peptide signals generated by ClpP that communicate mitochondrial stress to the nucleus, the tissue-specific substrate repertoire explaining Perrault syndrome's organ selectivity, and the structural basis for selectivity among chemically diverse ClpP activator scaffolds in clinical settings.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Retrograde signaling peptides produced by ClpP remain unidentified\", \"Tissue-specific ClpXP substrate profiles have not been mapped\", \"Resistance mechanisms to ClpP activators in tumors are unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 7, 9, 11, 19, 23, 25]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [1, 9, 12, 13, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 6, 7, 22, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [6, 7, 9, 23, 25]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [6, 23, 30]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [9, 32]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 22, 29]}\n    ],\n    \"complexes\": [\n      \"ClpXP\"\n    ],\n    \"partners\": [\n      \"CLPX\",\n      \"LONP1\",\n      \"SNCA\",\n      \"SHMT2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}